Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanded Access [11C] Methionine PET Imaging
Sponsor: St. Jude Children's Research Hospital
Summary
The participants are being asked to get this PET scan because the participants have or may have cancer in the central nervous system (head, neck, or spine), and the investigator and the patient's physician thinks that this scan may provide useful information for the participant's treatment. Primary Objective To provide expanded access to L-\[11C\]methionine as a positron-emitting tracer in children and young adults for the positron emission tomography (PET) imaging of neoplasms of the central nervous system (CNS) and head and neck to guide therapeutic management of disease.
Key Details
Gender
All
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-04-24
Healthy Volunteers
Not specified
Interventions
L-(11C) methionine
Injected intravenously with 20 mCi/1.7 sq m body surface area of L-\[methyl-11C\]methionine (maximum prescribed dose: 20 mCi).
Locations (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, United States